Estudos e Publicações



Em Andamento

 Axiomatic A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel (AXIOMATIC-SSP)

CHARM   Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large

ETHICHS   Esmolol for the Treatment of Hypertension after Intracerebral Hemorrhage Study 

INTERACT-3  The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 

OPTIMAL STROKE Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients

Resilient Direct TNK Randomization to EndoVascular Treatment Alone or Preceded by Systemic Thrombolysis with Tenecteplase in Acute Ischemic Stroke due to Large Intracranial VEssel OcclusioN Trial –DIRECT Thrombectomy vs. intravenous TNK plus thrombectomy 

Resilient Extend Randomization of Endovascular Treatment with Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke due to Large VEssel OcclusioN Trial in the Extended Time Window (RESILIENT- Extend)

Resilient Extend IV (início) – Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion with TNK (RESILIENT- Extend-IV)

TRIDENT   Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial.

Tempo 2  A Phase 3, Multi-Arm Multi-Stage Covariate-Adjusted Response-Adaptive Randomised Trial to Determine Optimal Early Mobility Training after Stroke (AVERT DOSE)

Avert-Dose – A trial to Determine the Optimal early mobility Training after StrokE 



Estudos Encerrados e suas Publicações

BASICS Basilar Artery International Cooperation Study

BRIDGE-STROKE Brazilian inteRvention to Increase eviDence usaGe in practicE Stroke

ENCHANTED Enchanced Control of Hypertension and Thrombolysis Stroke Study

HeadPoST  –  Head Position in Stroke Trial

RESILIENT Randomization of EndoVascular Treatment with Solitaire FR® vs. Best Medical Therapy in Acute Ischemic Stroke due to Large VEssel OcclusioN Trial)

THALES – Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death